Red Light Therapy for Plantar Fasciitis

Plantar fasciitis is the most common cause of heel pain, affecting roughly 1 in 10 people at some point in their lives. It accounts for approximately one million GP and specialist visits per year in the UK alone. The condition is notoriously stubborn — conventional treatments (rest, stretching, orthotics, steroid injections) help many people, but a significant minority experience chronic pain lasting months or even years.

Red light therapy — more precisely, photobiomodulation (PBM) — has accumulated a reasonable body of evidence for plantar fasciitis specifically. Unlike many conditions covered on this site where the evidence is largely mechanistic, plantar fasciitis has actual randomised controlled trials with PBM as the intervention. This page reviews that evidence honestly and provides practical protocols.

Understanding Plantar Fasciitis

The plantar fascia is a thick band of connective tissue running from the calcaneus (heel bone) to the base of the toes. It supports the longitudinal arch of the foot and absorbs mechanical load during walking, running, and standing.

What Goes Wrong

Despite the “-itis” suffix implying inflammation, plantar fasciitis is increasingly understood as a degenerative condition rather than a purely inflammatory one:

Early stage — acute inflammation at the calcaneal insertion point, with inflammatory mediators (prostaglandins, cytokines) present in the tissue
Chronic stage — the tissue undergoes degenerative changes: collagen disorganisation, fibroblast proliferation without proper repair, neovascularisation (abnormal new blood vessels), and mucoid degeneration. Some researchers prefer the term “plantar fasciosis” for this chronic phase

This distinction matters for treatment. Anti-inflammatory approaches (NSAIDs, ice, steroid injections) may help in the acute phase but are less effective — and potentially counterproductive — in the chronic degenerative phase. PBM, which promotes tissue repair and collagen remodelling as well as reducing inflammation, is theoretically suited to both phases.

Risk Factors

Overweight and obesity (strongest risk factor — increases mechanical load on the fascia)
Prolonged standing occupations
Running and high-impact sports
Tight calf muscles and Achilles tendon
Flat feet (pes planus) or very high arches (pes cavus)
Age 40–60 (peak incidence)
Wearing unsupportive footwear

What the Evidence Shows

Clinical Trials

Plantar fasciitis is one of the better-studied conditions in the PBM literature, with several randomised controlled trials:

Jastifer et al. (2014) conducted a randomised, double-blind, placebo-controlled trial published in Foot & Ankle International. Thirty patients with chronic plantar fasciitis received either active LLLT (830 nm, 60 mW, three treatment points on the heel) or sham treatment, three times per week for three weeks. The active group showed statistically significant improvements in pain scores (VAS) and functional outcomes (Foot Function Index) at the end of treatment and at the three-month follow-up. The authors concluded that LLLT “may be a viable alternative for the treatment of plantar fasciitis.”

Kiritsi et al. (2010) published a prospective study in Lasers in Medical Science examining 820 nm laser therapy for chronic plantar fasciitis. Twenty-five patients received PBM (energy density 4 J/cm²) over 12 sessions. Significant reductions in pain were observed at the end of treatment and maintained at the 12-week follow-up. Ultrasound imaging confirmed reductions in plantar fascia thickness — an objective measure of structural improvement.

Ulusoy et al. (2017) compared LLLT with extracorporeal shockwave therapy (ESWT) in a randomised trial of 60 patients with chronic plantar fasciitis, published in the Journal of Foot and Ankle Surgery. Both groups showed significant improvement in VAS pain scores and the American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Scale at six-month follow-up. Notably, LLLT was as effective as ESWT — a widely accepted treatment for refractory plantar fasciitis — with fewer reported side effects.

Basford et al. (1998) conducted an earlier double-blind RCT using 830 nm Nd:YAG laser for plantar fasciitis. The results were mixed — the treatment group showed greater improvement but the difference did not reach statistical significance. This study used a lower total energy dose than the more positive later trials, which may explain the marginal results.

Macias et al. (2015) performed a systematic review and meta-analysis of laser therapy for plantar fasciitis, published in the Journal of Clinical Orthopaedics and Trauma. The pooled analysis of six RCTs showed a statistically significant benefit of LLLT compared with placebo for pain reduction, with a moderate effect size. The authors noted that studies using higher energy densities (above 4 J/cm²) tended to show larger effects.

The Biological Mechanism

The clinical results align with known PBM mechanisms that are relevant to plantar fascia pathology:

Collagen remodelling — PBM stimulates fibroblast activity and promotes the production of organised type I collagen, which is the dominant collagen type in the plantar fascia. In a degenerated fascia, the disorganised collagen may be partially restored to a more functional arrangement
Anti-inflammatory effects — PBM reduces pro-inflammatory cytokines (IL-1beta, TNF-alpha, IL-6) and increases anti-inflammatory mediators. This is relevant in the acute phase but also in chronic fasciitis where low-grade inflammation persists
Angiogenesis — PBM promotes healthy new blood vessel formation, improving oxygen and nutrient delivery to the degenerative tissue. This contrasts with the abnormal neovascularisation seen in chronic fasciitis
Pain modulation — PBM has direct effects on nerve conduction and pain signalling, increasing pain thresholds at the treatment site. This provides symptomatic relief while the structural repair processes occur

Why NIR Wavelengths Matter for Plantar Fasciitis

The plantar fascia is a deep structure. At the calcaneal insertion (the typical site of maximum pain), the fascia sits beneath:

Skin (epidermis and dermis) — approximately 1–2 mm
Subcutaneous fat pad — 10–20 mm in the heel region
The fat pad of the heel is one of the thickest subcutaneous fat deposits in the body

This means near-infrared wavelengths (810–850 nm) are essential for plantar fasciitis treatment. Red light (630–660 nm) penetrates only 2–5 mm into tissue and will not reach the plantar fascia in most people. NIR at 810–850 nm penetrates 20–40 mm, sufficient to reach the fascial insertion.

The positive clinical trials above all used wavelengths in the 820–830 nm range — not red light. This is one condition where the common “red and NIR combination” recommendation is misleading. You need NIR, specifically.

Protocol for Plantar Fasciitis

Wavelength

810–850 nm (near-infrared) — this is non-negotiable for plantar fasciitis. Red wavelengths alone lack sufficient penetration depth
830 nm has the strongest trial evidence specifically for this condition

Dose

Energy density: 4–8 J/cm² per treatment point
Power density: 30–100 mW/cm² at the skin surface
If using a laser device (as in most clinical trials): 60–300 mW output, applied to 3–5 points on the heel and arch
If using an LED panel or pad: ensure the NIR irradiance at the treatment distance delivers adequate dose within 10–15 minutes

Treatment Points

Apply the light to three to five specific locations:

Medial calcaneal tubercle — the primary insertion point of the plantar fascia on the inner aspect of the heel. This is typically the point of maximum tenderness
Central heel — directly beneath the calcaneus
Proximal arch — 2–3 cm forward from the heel along the medial border of the foot
Mid-arch — the central portion of the plantar fascia
Any additional tender points along the fascia

Device Positioning

Direct contact or near-contact is ideal. Place the device directly against the sole of the foot
If using a panel, position the foot sole as close to the panel as possible (within 2–5 cm) and ensure the heel is centred on the treatment area
Wraps and pads designed for extremities are often the most practical format for plantar fasciitis, as they can conform to the foot shape and maintain consistent contact

Frequency and Duration

5 sessions per week for the first 4 weeks (the acute treatment phase)
3 sessions per week for weeks 5–12 (maintenance phase)
Minimum 12-week commitment before assessing whether PBM is working for you
Each session: 2–4 minutes per treatment point (at adequate power density) or 10–15 minutes total if using a pad/wrap covering the full plantar surface

Combination Approach (Recommended)

PBM works best for plantar fasciitis when combined with established conservative treatments:

Eccentric calf stretches — the single most evidence-based exercise for plantar fasciitis. Perform wall calf stretches (gastrocnemius and soleus) for 30 seconds each, three times, twice daily
Plantar fascia-specific stretching — cross one foot over the opposite knee and pull the toes back towards the shin for 30 seconds. Do this before getting out of bed in the morning
Supportive footwear and orthotics — wear shoes with good arch support; consider custom or over-the-counter orthotic insoles
Night splints — maintain the ankle at 90 degrees during sleep to prevent fascial contracture overnight
Body weight management — if overweight, even modest weight loss (5–10%) significantly reduces plantar fascia load

Use PBM as an adjunct to these measures, not as a replacement.

What Devices Work for Plantar Fasciitis

Not all red light therapy devices are suitable for plantar fasciitis. The key requirements are:

Must-Haves

NIR LEDs (810–850 nm) — devices with only red LEDs (630–660 nm) will not deliver adequate penetration
Sufficient irradiance — at least 20 mW/cm² at the treatment surface to deliver therapeutic doses in a practical timeframe

Best Device Formats

Flexible LED pads/wraps — these can be wrapped around the foot or placed against the sole, maintaining consistent contact. This is the most practical option for home use
Handheld laser devices — allow precise targeting of specific tender points. Many clinical trials used point-source lasers rather than LED arrays
Small tabletop panels — position the foot directly against the panel. Effective but slightly less convenient than wraps

Less Suitable Formats

LED face masks — wrong wavelength profile, wrong body part
Large full-body panels — will work if you can position your foot close enough, but overkill and impractical for a localised condition
Red-only devices — insufficient penetration depth for the plantar fascia

Realistic Expectations

Timeframe	What to Expect
Weeks 1–2	Some pain relief during and after sessions (acute analgesic effect)
Weeks 3–6	Gradual reduction in morning pain and first-step pain
Weeks 6–12	Structural improvement if responding — reduced tenderness, improved function
12+ weeks	Maximum benefit reached; transition to maintenance if effective

Who Responds Best

People with acute plantar fasciitis (less than 6 months duration)
Those who have not yet developed significant degenerative changes
People using PBM alongside stretching, orthotics, and load management

Who May Not Respond

Chronic cases (over 2 years) with established fascial degeneration may show limited improvement
People with significant heel fat pad atrophy (common in older adults) — though NIR penetration should still reach the fascia in most cases
Those expecting PBM alone to resolve the condition without addressing contributing factors (tight calves, unsupportive footwear, excess body weight)

The Honest Assessment

Plantar fasciitis is one of the conditions where the evidence for red light therapy is genuinely encouraging. Multiple RCTs show benefit, the mechanism is biologically plausible, and the treatment targets are accessible with appropriate NIR wavelengths.

That said, PBM is not a magic fix. The best results come from combining it with stretching, orthotics, and load management. If you have been struggling with plantar fasciitis for months and conventional treatments have provided only partial relief, adding NIR therapy is a reasonable and low-risk step.

The critical detail is wavelength: use 810–850 nm near-infrared, not red light. Devices that offer only 630–660 nm red LEDs will not deliver photons to the plantar fascia through the thick heel fat pad. This is one condition where the wrong wavelength choice means the treatment simply will not work, regardless of how long you use it.

This article is for informational purposes only and does not constitute medical advice. Plantar fasciitis can sometimes indicate other conditions (stress fractures, nerve entrapment, systemic inflammatory conditions). If your heel pain is severe, worsening, or accompanied by swelling, numbness, or systemic symptoms, consult a healthcare professional for proper diagnosis.